{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T10:48:55Z","timestamp":1767869335833,"version":"3.49.0"},"reference-count":19,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T00:00:00Z","timestamp":1767830400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Pulmonary Mucormycosis (PM), a severe fungal infection affecting mainly immunocompromised individuals, is often caused by fungi like Rhizopus and Mucor. This report details a 12-year-old diabetic girl with pulmonary mucormycosis from an unusual Rhizopus species. Successful treatment involved stabilizing her blood glucose and managing multiple co-infections. This case provides important insights into diagnosing and treating rare fungal infections in diabetic children.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case summary<\/jats:title>\n                    <jats:p>A 12-year-old girl with a two-year history of type 1 diabetes, inconsistently monitored, was hospitalized. She had a persistent cough for over ten days and a six-day high fever. Previous treatments with dexamethasone and antibiotics were ineffective. She showed symptoms of a productive cough, right-sided pleuritic chest pain, and a fever of 40\u00b0C. Examination revealed reduced breath sounds and moist rales in the right lung. Tests confirmed a severe infection, and imaging showed inflammatory consolidation, multiple cavitations, and pleural effusion in the right lung.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Diagnosis<\/jats:title>\n                    <jats:p>Metagenomic next-generation sequencing (mNGS) analyzes all nucleic acids from a patient\u2019s bronchoalveolar lavage fluid to identify various pathogens without traditional cultures. The analysis identified Rhizopus species and Streptococcus pneumoniae, confirming pulmonary mucormycosis with a bacterial infection. Additionally, the glycated hemoglobin (HbA1c) level was 14.3%, indicating poorly controlled diabetes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Treatment<\/jats:title>\n                    <jats:p>A comprehensive treatment regimen was employed. The bacterial co-infection was addressed with intravenous administration of meropenem and linezolid, while nebulized amphotericin B was utilized to treat the pulmonary mucormycosis. To mitigate the underlying risk factor, intensive glycemic control was achieved through the use of an insulin pump. Furthermore, bronchoscopy was conducted to clear respiratory secretions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Outcome<\/jats:title>\n                    <jats:p>After 11 days in the hospital, the patient stabilized and was discharged. At a follow-up 1.5 months later, infection markers and blood glucose levels were normal.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This case highlights the high risk of severe infections like pulmonary mucormycosis in adolescents with poorly managed type 1 diabetes. Metagenomic sequencing was crucial for quickly identifying co-infections. Successful treatment required a comprehensive approach, including targeted antimicrobial therapy, strict glycemic control, and bronchoscopic support, leading to a positive outcome.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fendo.2025.1724850","type":"journal-article","created":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T05:12:11Z","timestamp":1767849131000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Pulmonary mucormycosis with bacterial coinfection in an adolescent with poorly controlled type 1 diabetes: a case report"],"prefix":"10.3389","volume":"16","author":[{"given":"Fu","family":"Rong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhang","family":"Mingying","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bai","family":"Ying","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huang","family":"Yiyun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qian","family":"Ying","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xing","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chu","family":"Xiaolei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,1,8]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.cmi.2018.07.011","article-title":"The epidemiology and clinical manifestations of mucormycosis: a systematic review and meta-analysis of case reports","volume":"25","author":"Jeong","year":"2019","journal-title":"Clin Microbiol infection"},{"key":"B2","doi-asserted-by":"publisher","first-page":"102146","DOI":"10.1016\/j.dsx.2021.05.019","article-title":"Mucormycosis in COVID-19: a systematic review of cases reported worldwide and in India","volume":"15","author":"Jeong","year":"2021","journal-title":"Diabetes Metab Syndrome: Clin Res Rev"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1093\/jpids\/piz007","article-title":"Pediatric mucormycosis: a 10-year systematic review of reported cases and review of the literature","volume":"8","author":"Otto","year":"2019","journal-title":"J Pediatr Infect Dis Soc"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2021.541092","article-title":"Application of metagenomic next-generation sequencing in the diagnosis of pulmonary infectious pathogens from bronchoalveolar lavage samples","volume":"11","author":"Chen","year":"2021","journal-title":"Front Cell infection Microbiol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2024.1368165","article-title":"Clinical features of pediatric mucormycosis: role of metagenomic next generation sequencing in diagnosis","volume":"14","author":"Zhang","year":"2024","journal-title":"Front Cell Infection Microbiol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cir868","article-title":"Early clinical and laboratory diagnosis of invasive pulmonary, extrapulmonary, and disseminated mucormycosis (zygomycosis)","volume":"54","author":"Walsh","year":"2012","journal-title":"Clin Infect Dis"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)14904-5","article-title":"Glucocorticoids and invasive fungal infections","volume":"362","author":"Lionakis","year":"2003","journal-title":"Lancet"},{"key":"B8","doi-asserted-by":"publisher","first-page":"445","DOI":"10.3390\/jof8050445","article-title":"Mucormycosis and COVID-19-associated mucormycosis: insights of a deadly but neglected mycosis","volume":"8","author":"Garc\u00eda-Carnero","year":"2022","journal-title":"J Fungi"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cir865","article-title":"Pathogenesis of mucormycosis","volume":"54","author":"Ibrahim","year":"2012","journal-title":"Clin Infect Dis"},{"key":"B10","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1111\/j.1469-0691.2009.02983.x","article-title":"Molecular tools for identification of Zygomycetes and the diagnosis of zygomycosis","volume":"15","author":"Dannaoui","year":"2009","journal-title":"Clin Microbiol Infection"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.949505","article-title":"Application of metagenomic next-generation sequencing in the diagnosis of pulmonary invasive fungal disease","volume":"12","author":"Wang","year":"2022","journal-title":"Front Cell infection Microbiol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(19)30312-3","article-title":"Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium","volume":"19","author":"Cornely","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(20)30784-2","article-title":"Global guideline for the diagnosis and management of rare mould infections: an initiative of the European Confederation of Medical Mycology in cooperation with the International Society for Human and Animal Mycology and the American Society for Microbiology","volume":"21","author":"Hoenigl","year":"2021","journal-title":"Lancet Infect Dis"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1007\/s11046-017-0117-9","article-title":"Nebulized liposomal amphotericin B for treatment of pulmonary infection caused by hormographiella aspergillata: case report and literature review","volume":"182","author":"Godet","year":"2017","journal-title":"Mycopathologia"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.2337\/dc23-S016","article-title":"16. Diabetes care in the hospital: standards of care in diabetes-2023","volume":"46","author":"ElSayed","year":"2023","journal-title":"Diabetes Care"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjms.2015.11.011","article-title":"The effect of short-term hyperglycemia on the innate immune system","volume":"351","author":"Jafar","year":"2016","journal-title":"Am J Med Sci"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.15212\/bioi-2024-0005","article-title":"Population Study Insights Linked to Genetic Variants (rs16890979 and rs206833) and Type 2 Diabetes Control in Northern Jordan","volume":"5","author":"Al-Azzam","year":"2024","journal-title":"BIOI"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1097\/st9.0000000000000040","article-title":"Improvement of myocardial fibrosis injury by Shengmai injection in ischemia-induced heart failure in a rat model","volume":"2","author":"Ding","year":"2024","journal-title":"Sci Tradit Chin Med"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.4103\/mgr.MEDGASRES-D-23-00006","article-title":"Mechanisms of nitric oxide in spinal cord injury","volume":"14","author":"Hao","year":"2024","journal-title":"Med Gas Res"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1724850\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T05:12:13Z","timestamp":1767849133000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1724850\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,8]]},"references-count":19,"alternative-id":["10.3389\/fendo.2025.1724850"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2025.1724850","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,8]]},"article-number":"1724850"}}